Phase II trial of acivicin in advanced metastatic breast cancer.
D000328:Adult; D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010080:Oxazoles / Q000627:therapeutic use*
D007555:Isoxazoles; D010080:Oxazoles; C006303:acivicin